Unknown

Dataset Information

0

DNA damage response and prostate cancer: defects, regulation and therapeutic implications.


ABSTRACT: DNA damage response (DDR) includes the activation of numerous cellular activities that prevent duplication of DNA lesions and maintain genomic integrity, which is critical for the survival of normal and cancer cells. Specific genes involved in the DDR such as BRCA1/2 and P53 are mutated during prostate cancer progression, while various oncogenic signaling such as Akt and c-Myc are activated, enhancing the replication stress and increasing the genomic instability of cancer cells. These events may render prostate cancer cells particularly sensitive to inhibition of specific DDR pathways, such as PARP in homologous recombination DNA repair and Chk1 in cell cycle checkpoint and DNA repair, creating opportunities for synthetic lethality or synergistic cytotoxicity. Recent reports highlight the critical role of androgen receptor (AR) as a regulator of DDR genes, providing a rationale for combining DNA-damaging agents or targeted DDR inhibitors with hormonal manipulation or AR inhibition as treatment for aggressive disease. The aims of this review are to discuss specific DDR defects in prostate cancer that occur during disease progression, to summarize recent advances in understanding the regulation of DDR in prostate cancer, and to present potential therapeutic opportunities through combinational targeting of the intact components of DDR signaling pathways.

SUBMITTER: Karanika S 

PROVIDER: S-EPMC4333141 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA damage response and prostate cancer: defects, regulation and therapeutic implications.

Karanika S S   Karantanos T T   Li L L   Corn P G PG   Thompson T C TC  

Oncogene 20140818 22


DNA damage response (DDR) includes the activation of numerous cellular activities that prevent duplication of DNA lesions and maintain genomic integrity, which is critical for the survival of normal and cancer cells. Specific genes involved in the DDR such as BRCA1/2 and P53 are mutated during prostate cancer progression, while various oncogenic signaling such as Akt and c-Myc are activated, enhancing the replication stress and increasing the genomic instability of cancer cells. These events may  ...[more]

Similar Datasets

| S-EPMC8147657 | biostudies-literature
| S-EPMC6314076 | biostudies-literature
| S-EPMC7663807 | biostudies-literature
| S-EPMC5090703 | biostudies-literature
| S-EPMC5823274 | biostudies-literature
| S-EPMC6047242 | biostudies-literature
| S-EPMC8076026 | biostudies-literature
| S-EPMC8546664 | biostudies-literature
| S-EPMC2864659 | biostudies-literature